Literature DB >> 16572420

5-fluorouracil-related gene expression levels in primary colorectal cancer and corresponding liver metastasis.

Hidekazu Kuramochi1, Kazuhiko Hayashi, Kazumi Uchida, Satoru Miyakura, Daisuke Shimizu, Daniel Vallbohmer, Seongjin Park, Kathleen D Danenberg, Ken Takasaki, Peter V Danenberg.   

Abstract

Gene expression levels of thymidylate synthase (TS), dihydropyrimidine dehydrogenase (DPD), thymidine phosphorylase (TP) and orotate phosphoribosyl transferase (OPRT) have been shown to be associated with response to 5-fluorouracil-based therapies. Analyzing these gene expression levels in liver metastases is important to obtain the best prediction of therapy. Our aim was to determine how TS, DPD, TP and OPRT gene expression levels in primary colorectal cancer (CRC) were related to those in liver metastases. Formalin-fixed, paraffin-embedded tumor specimens from 31 pairs of primary CRC and corresponding liver metastases were dissected by using laser-captured microdissection. RNA was extracted and cDNA was prepared by reverse-transcription. Quantitation of target gene and internal reference gene was performed using real-time PCR. No significant difference was seen between median mRNA expression levels of TS, DPD, TP and OPRT in primary cancer and those in corresponding liver metastases (median value: TS 1.48 vs. 1.43; p=0.92, DPD 0.19 vs.0.12; p=0.10, TP 1.20 vs. 0.98; p=0.39, OPRT 1.17 vs. 0.95; p=0.10). When matched tissue sets were compared on an individual basis, there was a significant correlation for TS mRNA expression between primary cancer and corresponding liver metastases (rs=0.52, p=0.0026). However, no correlation was seen between matched sets for DPD, TP or OPRT. Significant correlation was seen between DPD and TP expression levels in both primary CRC (rs=0.38, p=0.03) and liver metastases (rs=0.72, p<0.0001). A good prediction of TS mRNA levels in liver metastases can be obtained by measuring those of primary CRC, although no correlation was seen for DPD, TP and OPRT. Copyright (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16572420     DOI: 10.1002/ijc.21692

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Elevated levels of mRNAs encoding dihydropyrimidine dehydrogenase and thymidylate synthase are associated with improved survival of patients with hepatocellular carcinoma treated with S-1.

Authors:  Yusuke Okano; Hidekazu Kuramochi; Go Nakajima; Satoshi Katagiri; Masakazu Yamamoto
Journal:  Oncol Lett       Date:  2017-05-24       Impact factor: 2.967

2.  S-1 and the treatment of gastric cancer with peritoneal dissemination.

Authors:  Kunihiko Izuishi; Reiji Haba; Yoshio Kushida; Kyuichi Kadota; Ryusuke Takebayashi; Takanori Sano; Hisashi Usuki; Mohammad Akram Hossain; Hirohito Mori; Tsutomu Masaki; Yasuyuki Suzuki
Journal:  Exp Ther Med       Date:  2011-06-20       Impact factor: 2.447

3.  Thymidylate synthase and thymidine phosphorylase mRNA expression in primary lesions using laser capture microdissection is useful for prediction of the efficacy of FOLFOX treatment in colorectal cancer patients with liver metastasis.

Authors:  Kensuke Kumamoto; Koki Kuwabara; Yusuke Tajima; Kunihiko Amano; Satoshi Hatano; Tomonori Ohsawa; Norimichi Okada; Keiichiro Ishibashi; Norihiro Haga; Hideyuki Ishida
Journal:  Oncol Lett       Date:  2012-02-09       Impact factor: 2.967

4.  Biological resonance for cancer metastasis, a new hypothesis based on comparisons between primary cancers and metastases.

Authors:  Dongwei Gao; Sha Li
Journal:  Cancer Microenviron       Date:  2013-11-10

5.  Amphiregulin and Epiregulin mRNA expression in primary colorectal cancer and corresponding liver metastases.

Authors:  Hidekazu Kuramochi; Go Nakajima; Yuka Kaneko; Ayako Nakamura; Yuji Inoue; Masakazu Yamamoto; Kazuhiko Hayashi
Journal:  BMC Cancer       Date:  2012-03-13       Impact factor: 4.430

6.  Thymidylate synthase, dihydropyrimidine dehydrogenase, ERCC1, and thymidine phosphorylase gene expression in primary and metastatic gastrointestinal adenocarcinoma tissue in patients treated on a phase I trial of oxaliplatin and capecitabine.

Authors:  Kazumi Uchida; Peter V Danenberg; Kathleen D Danenberg; Jean L Grem
Journal:  BMC Cancer       Date:  2008-12-23       Impact factor: 4.430

7.  Expression of HGF and Met in human tissues of colorectal cancers: biological and clinical implications for synchronous liver metastasis.

Authors:  Yan-lai Sun; Wei-dong Liu; Guo-yuan Ma; Dong-wei Gao; Yuan-zhu Jiang; Qi Liu; Jia-jun Du
Journal:  Int J Med Sci       Date:  2013-03-15       Impact factor: 3.738

8.  Thymidine phosphorylase expression is associated with time to progression in patients with metastatic colorectal cancer.

Authors:  Elinor Bexe Lindskog; Kristoffer Derwinger; Bengt Gustavsson; Peter Falk; Yvonne Wettergren
Journal:  BMC Clin Pathol       Date:  2014-06-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.